How did Aspen Aerogels' revenue and expenses trend in Q4 2024?
5/8/2025 09:17pm
Aspen Aerogels' revenue increased by 3.45% in Q4 2024, reaching $123.09 million, while the gross margin remained stable at 40.4%. However, the company's R&D expenses decreased by 5.6% to $4.41 million, and SG&A expenses increased by 7.4% to $27.21 million, indicating a shift in spending priorities.
|code|Ticker|Name|Date|Gross Profit Margin|R&D Expenses|Total Revenue|market_code|
|---|---|---|---|---|---|---|---|
|ASPN|ASPN.N|Aspen Aerogels|2024 Q1|37.188|4489000|9.4501E7|169|
|ASPN|ASPN.N|Aspen Aerogels|2024 Q2|40.8539|4565000|1.1777E8|169|
|ASPN|ASPN.N|Aspen Aerogels|2024 Q3|41.1892|4591000|1.1734E8|169|
|ASPN|ASPN.N|Aspen Aerogels|2024 Q4|40.4015|4405000|1.23088E8|169|